Surgery Partners, Inc. (NASDAQ:SGRY – Get Free Report) has received an average recommendation of “Moderate Buy” from the twelve brokerages that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, eight have assigned a buy rating and one has issued a strong buy rating on the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $22.1818.
Several analysts have issued reports on the company. Jefferies Financial Group reissued a “buy” rating and issued a $17.00 price target on shares of Surgery Partners in a research note on Wednesday, May 6th. Zacks Research upgraded Surgery Partners from a “hold” rating to a “strong-buy” rating in a report on Thursday, June 4th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Surgery Partners in a research report on Tuesday, May 26th.
View Our Latest Stock Report on Surgery Partners
Hedge Funds Weigh In On Surgery Partners
Surgery Partners Stock Down 3.9%
Shares of SGRY stock opened at $15.99 on Friday. Surgery Partners has a 12-month low of $11.41 and a 12-month high of $24.10. The company has a quick ratio of 1.69, a current ratio of 1.86 and a debt-to-equity ratio of 1.17. The firm has a fifty day moving average of $14.86 and a 200-day moving average of $14.45. The company has a market capitalization of $2.09 billion, a price-to-earnings ratio of -26.65, a P/E/G ratio of 4.78 and a beta of 1.89.
Surgery Partners (NASDAQ:SGRY – Get Free Report) last posted its quarterly earnings data on Tuesday, May 5th. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.15) by $0.12. The business had revenue of $810.90 million for the quarter, compared to analysts’ expectations of $797.69 million. Surgery Partners had a negative net margin of 2.28% and a positive return on equity of 1.04%. The firm’s revenue was up 4.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.04 EPS. As a group, equities research analysts predict that Surgery Partners will post 0.25 earnings per share for the current fiscal year.
About Surgery Partners
Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.
Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.
Read More
- Five stocks we like better than Surgery Partners
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.
